Epigenetic Analysis of the Chromatin Landscape Identifies a Repertoire of Murine Eosinophil-Specific PU.1-Bound Enhancers

Eosinophils develop in the bone marrow from hematopoietic progenitors into mature cells capable of a plethora of immunomodulatory roles via the choreographed process of eosinophilopoiesis. However, the gene regulatory elements and transcription factors (TFs) orchestrating this process remain largely unknown. The potency and resulting diversity fundamental to an eosinophil’s complex immunomodulatory functions and tissue specialization likely result from dynamic epigenetic regulation of the eosinophil genome, a dynamic eosinophil regulome. In this study, we applied a global approach using broad-range, next-generation sequencing to identify a repertoire of eosinophil-specific enhancers. We identified over 8200 active enhancers located within 1–20 kB of expressed eosinophil genes. TF binding motif analysis revealed PU.1 (Spi1) motif enrichment in eosinophil enhancers, and chromatin immunoprecipitation coupled with massively parallel sequencing confirmed PU.1 binding in likely enhancers of genes highly expressed in eosinophils. A substantial proportion (>25%) of these PU.1-bound enhancers were unique to murine, culture-derived eosinophils when compared among enhancers of highly expressed genes of three closely related myeloid cell subsets (macrophages, neutrophils, and immature granulocytes). Gene ontology analysis of eosinophil-specific, PU.1-bound enhancers revealed enrichment for genes involved in migration, proliferation, degranulation, and survival. Furthermore, eosinophil-specific superenhancers were enriched in genes whose homologs are associated with risk loci for eosinophilia and allergic diseases. Our collective data identify eosinophil-specific enhancers regulating key eosinophil genes through epigenetic mechanisms (H3K27 acetylation) and TF binding (PU.1). Visual Abstract Key Points Active (H3K27ac+) eosinophil–specific enhancers are enriched for PU.1. Active eosinophil–specific enhancers are enriched in key functional gene pathways. Eosinophil superenhancers associate with genes with risk loci for allergic disease.

[1]  Laura J. Norton,et al.  Eosinophil function in adipose tissue is regulated by Krüppel-like factor 3 (KLF3) , 2020, Nature Communications.

[2]  M. Weirauch,et al.  AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation , 2019, The Journal of experimental medicine.

[3]  J. Strouboulis,et al.  The Pleiotropic Effects of GATA1 and KLF1 in Physiological Erythropoiesis and in Dyserythropoietic Disorders , 2019, Front. Physiol..

[4]  Michael Kotliar,et al.  CWL-Airflow: a lightweight pipeline manager supporting Common Workflow Language , 2018, bioRxiv.

[5]  P. Fulkerson Transcription Factors in Eosinophil Development and As Therapeutic Targets , 2017, Front. Med..

[6]  T. Marichal,et al.  Homeostatic Eosinophils: Characteristics and Functions , 2017, Front. Med..

[7]  D. Broide,et al.  Smad3-Deficient Mice Have Reduced Esophageal Fibrosis and Angiogenesis in a Model of Egg-Induced Eosinophilic Esophagitis , 2014, Journal of pediatric gastroenterology and nutrition.

[8]  A. Rossi,et al.  Eosinophils in the Lung – Modulating Apoptosis and Efferocytosis in Airway Inflammation , 2014, Front. Immunol..

[9]  S. Mckercher,et al.  Myeloid development is selectively disrupted in PU.1 null mice. , 1998, Blood.

[10]  M. Simon,et al.  Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. , 1996, Current topics in microbiology and immunology.

[11]  D. Tenen,et al.  Interleukin-5 receptor alpha subunit gene regulation in human eosinophil development: identification of a unique cis-element that acts lie an enhancer in regulating activity of the IL-5R alpha promoter. , 1996, Current topics in microbiology and immunology.